Recovery products return despite continued slides in S&P 500

The US has seen a plethora of product issues in the past month that bank on a long-term recovery in equity markets, despite the S&P 500 index continuing its lacklustre performance. February was marked by tough operating conditions, with fewer than three launches on some days, and issuance grinding to a halt on one occasion.

However, a noticeable theme has been bullish products, usually accelerated growth structures, linked to the S&P 500. Sentiment therefore appears to indicate that the index has

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here